Range Financial Group LLC Buys 5,644 Shares of Colgate-Palmolive (NYSE:CL)

Range Financial Group LLC lifted its stake in Colgate-Palmolive (NYSE:CL) by 117.8% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 10,436 shares of the company’s stock after acquiring an additional 5,644 shares during the period. Range Financial Group LLC’s holdings in Colgate-Palmolive were worth $949,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Foundations Investment Advisors LLC bought a new stake in shares of Colgate-Palmolive during the 2nd quarter worth $225,000. Private Advisor Group LLC grew its position in shares of Colgate-Palmolive by 2.7% in the second quarter. Private Advisor Group LLC now owns 65,409 shares of the company’s stock valued at $6,347,000 after purchasing an additional 1,690 shares during the last quarter. Savant Capital LLC grew its position in shares of Colgate-Palmolive by 11.8% in the second quarter. Savant Capital LLC now owns 38,587 shares of the company’s stock valued at $3,744,000 after purchasing an additional 4,085 shares during the last quarter. Advisor OS LLC increased its stake in shares of Colgate-Palmolive by 4.5% in the second quarter. Advisor OS LLC now owns 2,348 shares of the company’s stock worth $228,000 after purchasing an additional 101 shares during the period. Finally, Strategic Financial Concepts LLC bought a new stake in Colgate-Palmolive during the 2nd quarter valued at approximately $178,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Trading Down 0.3 %

CL traded down $0.23 during trading on Tuesday, reaching $87.31. 4,758,771 shares of the company’s stock were exchanged, compared to its average volume of 4,280,894. The company’s fifty day moving average price is $93.18 and its 200-day moving average price is $98.38. The firm has a market capitalization of $71.33 billion, a PE ratio of 25.02, a P/E/G ratio of 3.31 and a beta of 0.44. Colgate-Palmolive has a fifty-two week low of $79.69 and a fifty-two week high of $109.30. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04.

Colgate-Palmolive Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.29%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 57.31%.

Insider Transactions at Colgate-Palmolive

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares of the company’s stock, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 0.34% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on CL. JPMorgan Chase & Co. upped their price target on Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. Deutsche Bank Aktiengesellschaft downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and increased their price target for the company from $107.00 to $109.00 in a report on Monday, September 9th. Stifel Nicolaus downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and dropped their price objective for the stock from $105.00 to $101.00 in a report on Monday, October 28th. Wells Fargo & Company cut their price objective on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research report on Tuesday. Finally, StockNews.com raised Colgate-Palmolive from a “hold” rating to a “buy” rating in a research report on Wednesday, January 1st. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $104.16.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.